Last updated: April 2026

Mochi Health vs Dr. House: Compare GLP-1 Programs & Pricing

Side-by-side Mochi Health and Dr. House: semaglutide/tirzepatide starting prices, promos, membership rules, and official links.

Mochi Health and Dr. House are two established telehealth providers offering GLP-1–based weight‑management programs. This article compares Mochi Health vs Dr. House to help you identify which best fits your goals and preferences.

Visit Mochi Health
Explore Dr. House

Mochi Health vs Dr. House: Quick Overview

Mochi Health vs Dr. House: Medical Process & Accessibility

Mochi Health focuses on a rapid telehealth intake, online questionnaires, and clinician approval within 24‑48 hours. After approval, a licensed pharmacy ships the compounded GLP‑1 medication directly to your door. Dr. House follows a similar virtual pathway but adds a scheduled video consult and a longer onboarding window to personalize dosing from day one.

Start with Mochi Health

Mochi Health vs Dr. House: Pricing Comparison

Mochi Health starts semaglutide at $99.00 and tirzepatide at $199.00. Because Dr. House does not publicly list starting prices on its public site, Mochi Health currently offers the more transparent and lower entry point. Both providers require a prescription from a U.S.‑licensed clinician, and the medication is compounded by accredited pharmacies.

Membership fees differ as well. Mochi Health charges a monthly $79.99 membership that unlocks unlimited virtual visits and dose‑adjustment support. Dr. House does not require a membership, so there are no recurring fees beyond the medication cost itself.

Compare Dr. House Pricing

Mochi Health vs Dr. House: Clinical Oversight & Support

Both platforms assign a board‑certified endocrinologist or obesity‑medicine specialist to review your intake forms. Mochi Health’s model emphasizes quick prescription turnaround, whereas Dr. House provides a more hands‑on approach with scheduled follow‑ups at weeks 2, 4, and 8 to monitor side effects and titrate dosage.

Book a Consultation with Mochi Health

Mochi Health vs Dr. House: Medication Quality & Safety

Both companies dispense compounded semaglutide or tirzepatide from FDA‑registered compounding pharmacies. While these formulations are not the brand‑name products Wegovy® or Mounjaro®, they contain the same active ingredient at equivalent dosages and are legally prescribed under telehealth supervision. Each provider requires a thorough medical history, a recent lab panel (if available), and a signed consent form to mitigate risks.

Mochi Health vs Dr. House: Customer Experience

Patient reviews on independent forums frequently cite Mochi Health’s affordability and rapid shipping (average 3‑5 business days). Dr. House is praised for its detailed educational resources, personalized coaching calls, and proactive side‑effect monitoring. Both companies report a 95% medication‑delivery success rate and a high satisfaction score for overall program experience.

Explore Dr. House Reviews

Mochi Health vs Dr. House: Final Verdict

If cost‑sensitivity and swift onboarding are your top priorities, Mochi Health is the clear choice. Its transparent $99 start‑up price for semaglutide, $199 for tirzepatide, and a modest $79.99 membership make it an attractive entry point for many patients.

If you prefer a program with structured clinical follow‑up, no membership commitment, and a more hands‑on coaching model, Dr. House may better align with your expectations. Both providers operate under U.S. telehealth regulations, employ licensed clinicians, and partner with FDA‑registered pharmacies, ensuring safety and compliance.

Join Mochi Health
Get Started with Dr. House

Disclaimer

This article is for informational purposes only and does not constitute medical advice. ExploreProviders may receive affiliate commissions at no cost to you. Always consult a licensed clinician before beginning any medical treatment.